Su YC - Search Results

1

Mortality of patients with metastatic colorectal cancer who received elective or emergent operation after exposure to bevacizumab: A nationwide database study.

Chen YH, Su YC, Hsu CW, Hsieh MC, Wang YC, Lee MH, Lin CY, Chang YC, Wu CC. Chen YH, et al. Among authors: su yc. Eur J Surg Oncol. 2023 Feb;49(2):445-451. doi: 10.1016/j.ejso.2022.09.018. Epub 2022 Oct 1. Eur J Surg Oncol. 2023. PMID: 36208981

2

Colchicine-Induced Acute Neuromyopathy in a Patient Using Concomitant Fluconazole: Case Report and Literature Review.

Su YC, Wu CC. Su YC, et al. Drug Saf Case Rep. 2015 Dec;2(1):16. doi: 10.1007/s40800-015-0020-6. Drug Saf Case Rep. 2015. PMID: 27747728 Free PMC article.

3

Risk of nephrotoxicity among patients who received vancomycin.

Su YC, Lin PC, Wu CC. Su YC, et al. Infect Dis (Lond). 2018 Feb;50(2):152-155. doi: 10.1080/23744235.2017.1366046. Epub 2017 Aug 17. Infect Dis (Lond). 2018. PMID: 28816069 No abstract available.

4

Hepatitis B virus reactivation in patients with resolved hepatitis B virus infection receiving chemotherapy or immunosuppressive therapy.

Su YC, Lin PC, Yu HC, Wu CC. Su YC, et al. Eur J Gastroenterol Hepatol. 2018 Aug;30(8):925-929. doi: 10.1097/MEG.0000000000001130. Eur J Gastroenterol Hepatol. 2018. PMID: 29621049

5

Antiviral prophylaxis during chemotherapy or immunosuppressive drug therapy to prevent HBV reactivation in patients with resolved HBV infection: a systematic review and meta-analysis.

Su YC, Lin PC, Yu HC, Wu CC. Su YC, et al. Eur J Clin Pharmacol. 2018 Sep;74(9):1111-1119. doi: 10.1007/s00228-018-2487-4. Epub 2018 May 29. Eur J Clin Pharmacol. 2018. PMID: 29845351 Review.

6

Tumor sidedness and efficacy of first-line therapy in patients with RAS/BRAF wild-type metastatic colorectal cancer: A network meta-analysis.

Wu CC, Wang JH, Lin PC, Liang CA, Huang CY, Lien HC, Chen CY, Chou KJ, Su YC. Wu CC, et al. Among authors: su yc. Crit Rev Oncol Hematol. 2020 Jan;145:102823. doi: 10.1016/j.critrevonc.2019.102823. Epub 2019 Nov 15. Crit Rev Oncol Hematol. 2020. PMID: 31783291

7

Loading dose and efficacy of continuous or extended infusion of beta-lactams compared with intermittent administration in patients with critical illnesses: A subgroup meta-analysis and meta-regression analysis.

Wu CC, Su YC, Wu KS, Wu TH, Yang CS. Wu CC, et al. Among authors: su yc. J Clin Pharm Ther. 2021 Apr;46(2):424-432. doi: 10.1111/jcpt.13301. Epub 2020 Nov 2. J Clin Pharm Ther. 2021. PMID: 33135261

8

Shared decision-making and patient decision aids in choosing first-line targeted therapy for metastatic colorectal cancer in Taiwan.

Wu CC, Wang JH, Chang MC, Chen YH, Wang YC, Lee MH, Lin CY, Su YC, Lin PC, Hsu CW. Wu CC, et al. Among authors: su yc. J Oncol Pharm Pract. 2022 Sep;28(6):1293-1302. doi: 10.1177/10781552211020806. Epub 2021 Jun 1. J Oncol Pharm Pract. 2022. PMID: 34060351

9

Optimal Sequence and Second-Line Systemic Treatment of Patients with RAS Wild-Type Metastatic Colorectal Cancer: A Meta-Analysis.

Wu CC, Hsu CW, Hsieh MC, Wang JH, Chang MC, Yang CS, Su YC. Wu CC, et al. Among authors: su yc. J Clin Med. 2021 Nov 4;10(21):5166. doi: 10.3390/jcm10215166. J Clin Med. 2021. PMID: 34768686 Free PMC article.

10

Comparative Effectiveness of Bevacizumab versus Cetuximab in Metastatic Colorectal Cancer Patients without Primary Tumor Resection.

Su YC, Wu CC, Su CC, Hsieh MC, Cheng CL, Kao Yang YH. Su YC, et al. Among authors: su cc. Cancers (Basel). 2022 Apr 24;14(9):2118. doi: 10.3390/cancers14092118. Cancers (Basel). 2022. PMID: 35565247 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,198 results

Search Page

Filters